231 related articles for article (PubMed ID: 28626072)
1. 5-HT causes splanchnic venodilation.
Seitz BM; Orer HS; Krieger-Burke T; Darios ES; Thompson JM; Fink GD; Watts SW
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H676-H686. PubMed ID: 28626072
[TBL] [Abstract][Full Text] [Related]
2. 5-HT7 Receptor Restrains 5-HT-induced 5-HT2A Mediated Contraction in the Isolated Abdominal Vena Cava.
Gonzalez-Pons R; McRae K; Thompson JM; Watts SW
J Cardiovasc Pharmacol; 2021 Aug; 78(2):319-327. PubMed ID: 34029269
[TBL] [Abstract][Full Text] [Related]
3. 5-HT does not lower blood pressure in the 5-HT
Seitz BM; Demireva EY; Xie H; Fink GD; Krieger-Burke T; Burke WM; Watts SW
Physiol Genomics; 2019 Jul; 51(7):302-310. PubMed ID: 31125292
[TBL] [Abstract][Full Text] [Related]
4. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.
Davis RP; Pattison J; Thompson JM; Tiniakov R; Scrogin KE; Watts SW
BMC Pharmacol; 2012 May; 12():4. PubMed ID: 22559843
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic circulation.
Darios ES; Barman SM; Orer HS; Morrison SF; Davis RP; Seitz BM; Burnett R; Watts SW
Eur J Pharmacol; 2015 May; 754():140-7. PubMed ID: 25732865
[TBL] [Abstract][Full Text] [Related]
6. 5-HT is a potent relaxant in rat superior mesenteric veins.
Watts SW; Darios ES; Seitz BM; Thompson JM
Pharmacol Res Perspect; 2015 Feb; 3(1):e00103. PubMed ID: 25692021
[TBL] [Abstract][Full Text] [Related]
7. β-arrestin biased signaling is not involved in the hypotensive actions of 5-HT
Watts SW; Garver H; Morisset-Lopez S; Suzenet F; Fink GD
Pharmacol Res; 2024 Jan; 199():107047. PubMed ID: 38157998
[TBL] [Abstract][Full Text] [Related]
8. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
Fernández MM; Morán A; Martín ML; San Román L
Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
[TBL] [Abstract][Full Text] [Related]
9. Activation of the 5-HT
Seitz BM; Fink GD; Watts SW
Exp Physiol; 2020 Dec; 105(12):2025-2032. PubMed ID: 33052620
[TBL] [Abstract][Full Text] [Related]
10. Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor.
Villalón CM; Centurión D; Luján-Estrada M; Terrón JA; Sánchez-López A
Br J Pharmacol; 1997 Apr; 120(7):1319-27. PubMed ID: 9105708
[TBL] [Abstract][Full Text] [Related]
11. Unravelling the pharmacological profile of the canine external carotid vasodilator '5-HT1-like' receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors.
Villalón CM; Sánchez-López A; Centurión D; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):73-80. PubMed ID: 11191839
[TBL] [Abstract][Full Text] [Related]
12. A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction.
Harsing LG; Prauda I; Barkoczy J; Matyus P; Juranyi Z
Neurochem Res; 2004 Aug; 29(8):1487-97. PubMed ID: 15260125
[TBL] [Abstract][Full Text] [Related]
13. Mediation of 5-HT-induced internal carotid vasodilatation in GR127935- and ritanserin-pretreated dogs by 5-HT7 receptors.
Centurión D; Sánchez-López A; Ortiz MI; De Vries P; Saxena PR; Villalón CM
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):169-76. PubMed ID: 10961380
[TBL] [Abstract][Full Text] [Related]
14. Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat.
Terrón JA
Br J Pharmacol; 1997 Jun; 121(3):563-71. PubMed ID: 9179401
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus.
Markstein R; Matsumoto M; Kohler C; Togashi H; Yoshioka M; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):454-9. PubMed ID: 10431755
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-HT3 receptors in activation of abdominal sympathetic C fibre afferents during ischaemia in cats.
Fu LW; Longhurst JC
J Physiol; 1998 Jun; 509 ( Pt 3)(Pt 3):729-40. PubMed ID: 9596795
[TBL] [Abstract][Full Text] [Related]
17. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C
Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries.
Morecroft I; MacLean MR
Br J Pharmacol; 1998 Sep; 125(1):69-78. PubMed ID: 9776346
[TBL] [Abstract][Full Text] [Related]
19. Functional evaluation of 5-hydroxytryptamine receptor activity in rat resistance vessels.
Potenza MA; Serio M; Montagnani M; Mansi G; Rinaldi R; Genualdo M; Mitolo-Chieppa D
J Auton Pharmacol; 1998 Apr; 18(2):75-81. PubMed ID: 9730261
[TBL] [Abstract][Full Text] [Related]
20. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
Banes AK; Watts SW
Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
